Authors


A. H. Calhoun, MD

Latest:

Concepts in Acute Migraine Management: Clinical and Managed Care Perspectives

Patients, payers, providers, and employers are affected by misdiagnosis, undertreatment, and inappropriate management of migraine.


Gary K. Rice, RPh, MS, MBA

Latest:

Raising the Bar Through Education and Quality Initiatives

From its creation, Diplomat University at Diplomat Specialty Pharmacy has been structured around its primary objective to provide a high-level of ongoing education to enable staff and partners to take the best possible care of patients.


Jimmy Stevens, PharmD

Latest:

Urinary Tract Infections Affect Men as Well as Women

Pharmacists can help male patients prevent, identify, and treat these bacterial conditions.


Brita Hedblom, BS

Latest:

Barriers to and Facilitators of Medication Adherence

This study reports on barriers to and facilitators of medication adherence for asthma and diabetes patients who were both adherent and nonadherent to their medication regimen.


Raniah Aljadeed, Bsc Pharm, PharmD

Latest:

Pain Management: A Review of Tramadol and Associated Seizure

Seizures triggered by tramadol have been observed with higher and lower doses, and co-ingestion of alcohol, tricyclic antidepressants, antipsychotics, and selective serotonin reuptake inhibitors.



Christina A. Spivey, PhD

Latest:

Economic Outcomes of Warfarin Discontinuation Among Patients with Atrial Fibrillation

This study seeks to determine the economic effects of warfarin discontinuation in patients with nonvalvular atrial fibrillation.


Neha Bhardwaj, PharmD Candidate

Latest:

Dental Overprescribing of Opioids for Pain Management

In a recent study analyzing US commercial dental visits between 2011 and 2015, 29.3% of dental visits included opioid prescriptions that exceeded the recommended amount of less than 80 morphine milligram equivalents.


Alyssa Wozniak, PharmD, BCPS

Latest:

Focus on Smoking Cessation During COVID-19: Review of Varenicline Pharmacogenomics

Patients with current or former smoking status may be at an increased risk of severe illness due to COVID-19.


Christopher L. Cook, PharmD, PhD

Latest:

Guest Commentary: Health Care Crossroads—Where Do We Go from Here?

Chronic disease is the primary driver of health care costs. A focus on coordinated, patient-centered care initiatives will help lessen its impact on patients and pocketbooks.


Tania Gregorian, PharmD

Latest:

Immunizations and Health Disparities: Immunizations Provided Across a Diverse Population

Vaccines help contain the spread of diseases and reduce morbidity and mortality.



Shannon Wiley

Latest:

What’s All the Fuss? Core Versus Enhanced Services

Core services are basic to specialty pharmacy offerings, while enhanced services are only provided with payment from a third party, usually a drug manufacturer.


Marc Duey, MSc, MBA, president, ProMetrics

Latest:

Speed-to-Therapy Insights in Specialty Pharmacy

It is important to measure speed-to-therapy for specialty drugs to evaluate how much time it takes manufacturers, physicians, insurance companies, hubs, and specialty pharmacies to get essential medications to patients.



Cassian Widenhofer, PharmD Candidate

Latest:

Specialty Pharmacies Improve Patient Outcomes, Minimize Costs to Health Care System

The goals of specialty pharmacy programs are to reduce or delay progression of the disease, improve patient outcomes, enhance patients’ quality of life, keep patients in the workforce longer, and decrease total health care costs.


Kenneth Maxik, MBA, MBB, FACHE

Latest:

Help Patients Safely Handle Medications to Improve Adherence

Addressing barriers such as cognitive impairment, cultural issues, and denial can help patients avoid adverse effects.


Allison B. Blackmer, PharmD, BCPS

Latest:

Parenteral Nutrition: Complications of Long-Term Use in Pediatric Patients

Cholestasis is a serious complication of long-term parenteral nutrition use.


Robin C. Wackernah, PharmD, BCPP

Latest:

Drug-Induced Liver Injury in Children: Atomoxetine and Nonstimulants for ADHD

Mechanisms of drug-induced liver injury in children, case reports of atomoxetine-induced liver injury in children, and nonstimulant options for attention-deficit/hyperactivity disorder.


National Healthcareer Association

Latest:

Effective Communication Can Make or Break Your Business

A guide to promoting effective communication among your pharmacy technicians.


Arijit Ganguli, BS Pharm, MBA

Latest:

Impact of New Antihypertensives on Healthcare Utilization by Hypertensive Patients

The authors advocate pharmacoeconomic evaluation of new antihypertensive drugs before acceptance by formulary decision makers.


Ayesha Khan, PharmD, BCPS

Latest:

How to Address Bleeding Reversal in Synthetic Cannabinoid Users

The CDC and local poison control centers offer useful guidance for best practices.


Danielle W. Donaldson, PharmD

Latest:

Patient Characteristics' Effect on the Conversion Between Basal Insulins

The characteristics of patients who require increases in their basal insulin dose were compared with those requiring no increase following conversion between basal insulin analogues.


Thomas Lodise, PharmD, PhD

Latest:

Advice for Physicians to Manage C. Difficile Infection (CDI)

Experts share advice for physicians taking care of patients with C. difficile infection (CDI).


Ryan Marotta

Latest:

Antibiotics Are Overprescribed for Pink Eye

Recent study results indicate that antibiotic eye drops, despite being ineffective against viral infections and unnecessary for bacterial ones, are often prescribed for patients with acute conjunctivitis.


Lisa Nezneski, PharmD, BCPS, Managing Consultant, McKesson 340B Solutions

Latest:

Understanding and Navigating Specialty and Orphan Drug Challenges in the 340B Program

Failure to recognize the interests of manufacturers to ensure proper use of 340B pricing may result in 340B hospitals missing the opportunity to secure and retain discounts on key orphan and specialty drugs or may render them unable to access the drugs at all.



Erica Conroy, PhD

Latest:

Help Patients Obtain HIV Medications

Learn how retail or specialty pharmacy distribution can affect access to these important drugs.



Ashley R. Miller, PharmD

Latest:

Trends in Statin Treatment Costs and Potential Impact of Novel Therapies

Generic atorvastatin led to an increase in generic dispensing rate and a reduction in the cost of treatment for patients requiring cholesterol-lowering treatment. The upcoming introduction of the PCSK9 inhibitor may change this trend.